ロード中...
Hydroxyurea Treated β-Thalassemia Children Demonstrate a Shift in Metabolism Towards Healthy Pattern
Augmentation of fetal hemoglobin (HbF) production has been an enduring therapeutic objective in β-thalassemia patients for which hydroxyurea (HU) has largely been the drug of choice and the most cost-effective approach. A serum metabolomics study on 40 patients with β-thalassemia prior to and after...
保存先:
| 出版年: | Sci Rep |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6182004/ https://ncbi.nlm.nih.gov/pubmed/30310134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-33540-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|